ESMO Virtual 2020: Impact of immunotherapy on quality of life
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]
Two online surveys presented at the European Society of Medical [...]
In a paper presented at this year’s European Society of [...]
Yesterday, findings from the phase 2 biomarker trial, BIONIKK, were [...]
At the European Society of Medical Oncology (ESMO) Virtual Congress [...]
Non-clear cell renal cell carcinoma (RCC) accounts for about 25% [...]
At the European Society of Medical Oncology (ESMO) Virtual Congress [...]
Over the past 2 years, the use of combination therapies [...]
The European Society for Medical Oncology (ESMO) has released a [...]
The use of artificial intelligence (AI) in clinical practice using [...]